CN115480005A - Detection method and application of 2-hexyldecanoic acid - Google Patents
Detection method and application of 2-hexyldecanoic acid Download PDFInfo
- Publication number
- CN115480005A CN115480005A CN202211074923.2A CN202211074923A CN115480005A CN 115480005 A CN115480005 A CN 115480005A CN 202211074923 A CN202211074923 A CN 202211074923A CN 115480005 A CN115480005 A CN 115480005A
- Authority
- CN
- China
- Prior art keywords
- mobile phase
- balance
- cad
- hplc
- detection
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229950004531 hexyldecanoic acid Drugs 0.000 title claims abstract description 30
- JMOLZNNXZPAGBH-UHFFFAOYSA-N hexyldecanoic acid Chemical compound CCCCCCCCC(C(O)=O)CCCCCC JMOLZNNXZPAGBH-UHFFFAOYSA-N 0.000 title claims abstract description 28
- 238000001514 detection method Methods 0.000 title claims abstract description 24
- 238000000034 method Methods 0.000 claims abstract description 44
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical group CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 54
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 16
- 238000010828 elution Methods 0.000 claims description 15
- 239000000243 solution Substances 0.000 claims description 15
- QGWBEETXHOVFQS-UHFFFAOYSA-N 6-[6-(2-hexyldecanoyloxy)hexyl-(4-hydroxybutyl)amino]hexyl 2-hexyldecanoate Chemical compound CCCCCCCCC(CCCCCC)C(=O)OCCCCCCN(CCCCO)CCCCCCOC(=O)C(CCCCCC)CCCCCCCC QGWBEETXHOVFQS-UHFFFAOYSA-N 0.000 claims description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 9
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims description 8
- 235000019253 formic acid Nutrition 0.000 claims description 8
- 239000007788 liquid Substances 0.000 claims description 8
- 230000005526 G1 to G0 transition Effects 0.000 claims description 6
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 6
- 238000007865 diluting Methods 0.000 claims description 5
- 239000002904 solvent Substances 0.000 claims description 5
- 238000004704 ultra performance liquid chromatography Methods 0.000 claims description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 3
- 238000003908 quality control method Methods 0.000 claims description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 3
- 238000010790 dilution Methods 0.000 claims description 2
- 239000012895 dilution Substances 0.000 claims description 2
- 238000002347 injection Methods 0.000 claims description 2
- 239000007924 injection Substances 0.000 claims description 2
- 239000002245 particle Substances 0.000 claims description 2
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 2
- 239000007864 aqueous solution Substances 0.000 claims 1
- 238000001303 quality assessment method Methods 0.000 claims 1
- 239000000741 silica gel Substances 0.000 claims 1
- 229910002027 silica gel Inorganic materials 0.000 claims 1
- 239000000126 substance Substances 0.000 abstract description 14
- 238000000926 separation method Methods 0.000 abstract description 3
- 238000011002 quantification Methods 0.000 abstract description 2
- 239000012071 phase Substances 0.000 description 36
- 239000012535 impurity Substances 0.000 description 17
- 239000000523 sample Substances 0.000 description 13
- 238000001819 mass spectrum Methods 0.000 description 10
- 230000014759 maintenance of location Effects 0.000 description 9
- 238000010829 isocratic elution Methods 0.000 description 6
- 239000007858 starting material Substances 0.000 description 5
- 239000012490 blank solution Substances 0.000 description 4
- 239000012488 sample solution Substances 0.000 description 4
- 238000005303 weighing Methods 0.000 description 4
- 239000000463 material Substances 0.000 description 3
- 238000001228 spectrum Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- SXIFAEWFOJETOA-UHFFFAOYSA-N 4-hydroxy-butyl Chemical group [CH2]CCCO SXIFAEWFOJETOA-UHFFFAOYSA-N 0.000 description 2
- HSBMBJDVXFRTTD-UHFFFAOYSA-N C(CCCCC)C(C(=O)OCCCCCCOC(C(CCCCCCCC)CCCCCC)=O)CCCCCCCC Chemical compound C(CCCCC)C(C(=O)OCCCCCCOC(C(CCCCCCCC)CCCCCC)=O)CCCCCCCC HSBMBJDVXFRTTD-UHFFFAOYSA-N 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 239000011550 stock solution Substances 0.000 description 2
- 239000003643 water by type Substances 0.000 description 2
- XULHFMYCBKQGEE-UHFFFAOYSA-N 2-hexyl-1-Decanol Chemical compound CCCCCCCCC(CO)CCCCCC XULHFMYCBKQGEE-UHFFFAOYSA-N 0.000 description 1
- JMOLZNNXZPAGBH-UHFFFAOYSA-M 2-hexyldecanoate Chemical compound CCCCCCCCC(C([O-])=O)CCCCCC JMOLZNNXZPAGBH-UHFFFAOYSA-M 0.000 description 1
- SQPZLZZLAPHSPL-UHFFFAOYSA-N 2-hexyloctanoic acid Chemical compound CCCCCCC(C(O)=O)CCCCCC SQPZLZZLAPHSPL-UHFFFAOYSA-N 0.000 description 1
- BLFRQYKZFKYQLO-UHFFFAOYSA-N 4-aminobutan-1-ol Chemical compound NCCCCO BLFRQYKZFKYQLO-UHFFFAOYSA-N 0.000 description 1
- 241000711573 Coronaviridae Species 0.000 description 1
- 238000013353 HPLC-CAD method Methods 0.000 description 1
- 229940026233 Pfizer-BioNTech COVID-19 vaccine Drugs 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000005576 amination reaction Methods 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- ZSIAUFGUXNUGDI-UHFFFAOYSA-N hexan-1-ol Chemical class CCCCCCO ZSIAUFGUXNUGDI-UHFFFAOYSA-N 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 238000013441 quality evaluation Methods 0.000 description 1
- 238000004366 reverse phase liquid chromatography Methods 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- 239000013076 target substance Substances 0.000 description 1
- 238000001196 time-of-flight mass spectrum Methods 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/62—Detectors specially adapted therefor
- G01N30/72—Mass spectrometers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N2030/022—Column chromatography characterised by the kind of separation mechanism
- G01N2030/027—Liquid chromatography
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Physics & Mathematics (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
Abstract
The invention discloses a detection method of 2-hexyldecanoic acid and application thereof. The method can rapidly and accurately separate the product and related substances through HPLC-CAD, can accurately measure the purity of the product in a linear range, is convenient and fast to operate and good in separation, and effectively controls the purity of the product through a high-low concentration method. The method meets the standard in the aspects of quantification, linear range and the like.
Description
Technical Field
The invention relates to the technical field of chemical analysis, in particular to a detection method of ALC-0315 starting material 2-hexyldecanoic acid and application thereof.
Background
ALC-0315 is a cationic biodegradable lipid, which is a colorless oily substance with the chemical name ((4-hydroxybutyl) azedinyl) bis (hexane-6, 1-diyl) bis (2-hexyldecanoate), and is attracting attention as a component of a novel coronavirus (SARS) vaccine BNT162b2 produced by BioNTech and fevere.
Chinese patent document CN114249662A discloses a preparation method of ALC-0315, which comprises the following steps: s1, performing azeotropic dehydration on 6-halogenated hexanol, 2-hexyldecanoic acid and a water-carrying agent to perform esterification reaction to obtain 6-halogenated hexanol-2-hexyldecanoate; s2, in the presence of an acid binding agent, performing amination reaction on 6-halogenated hexanol-2-hexyldecanoate and 4-aminobutanol in a solvent to obtain ALC-0315.
2-hexyldecanoic acid is an important raw material for producing ALC-0315, and no report specific to detection of 2-hexyldecanoic acid is found.
Disclosure of Invention
In order to overcome the defects of the prior art, the invention provides a detection method of 2-hexyldecanoic acid and application thereof.
In a first aspect of the present invention, a method for detecting 2-hexyldecanoic acid is provided, which comprises the step of detecting a sample to be detected by a high performance liquid chromatography-electrospray detector (HPLC-CAD).
In particular, the stationary phase of HPLC-CAD is octadecyl bonded silica, such as the ACQUITY UPLC BEH series.
In particular, the stationary phase has a particle size of 1 to 10 μm (e.g. 1, 2, 3, 4, 5, 6, 7, 8, 9, 10 μm), especially 1 to 5 μm, e.g. 1.7 μm.
In one embodiment of the invention, the stationary phase is Waters, acquisition UPLC BEH,2.1mm x 100mm;1.7 μm.
In some embodiments of the invention, the high performance liquid chromatograph used is a ThermoUltiMate 3000 high performance liquid chromatograph.
In some embodiments of the invention, the chromatographic station is Chromeleon.
In particular, the column temperature of the HPLC-CAD is in the range of 30-50 deg.C (e.g. 30, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 50 deg.C), in particular 35-45 deg.C, e.g. 40 deg.C.
Specifically, the mobile phase of HPLC-CAD consists of a mobile phase aqueous phase (a) and a mobile phase organic phase (B).
In particular, the mobile phase a is an aqueous formic acid solution having a concentration of 0.01 to 1% (by volume) (for example 0.01%, 0.05%, 0.1%, 0.15%, 0.2%, 0.4%, 0.5%, 1%), in particular 0.05 to 0.2%, for example 0.1%.
In particular, mobile phase B is a formic acid solution in acetonitrile at a concentration of 0.01 to 1% (by volume) (for example 0.01%, 0.05%, 0.1%, 0.15%, 0.2%, 0.4%, 0.5%, 1%), in particular 0.05 to 0.2%, for example 0.1%.
In particular, the flow rate of the mobile phase is from 0.1 to 1mL/min (e.g., 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1.0 mL/min), particularly from 0.1 to 0.5mL/min, e.g., 0.3mL/min.
Preferably, the HPLC-CAD detection employs a gradient elution; more preferably, the elution procedure comprises:
0-0.01min, mobile phase B,0 → 60-70% (e.g., 60%, 62%, 64%, 65%, 66%, 68%, 70%), mobile phase a, the balance;
0.01-17min, mobile phase B,60-70% (e.g., 60%, 62%, 64%, 65%, 66%, 68%, 70%), mobile phase a, the balance;
17-17.1min, mobile phase B,60-70% (e.g., 60%, 62%, 64%, 65%, 66%, 68%, 70%) → 100%, mobile phase a, and the balance
17.1-27min, mobile phase B,100%;
27-27.1min, mobile phase B,100% → 60-70% (e.g., 60%, 62%, 64%, 65%, 66%, 68%, 70%), mobile phase a, the balance;
27.1-37min, mobile phase B,60-70% (e.g., 60%, 62%, 64%, 65%, 66%, 68%, 70%), mobile phase a, the balance;
37min,stop。
in a preferred embodiment of the invention, the elution procedure comprises:
0-0.01min, mobile phase B,0 → 65%, mobile phase A, and the balance;
0.01-17min, 65% of mobile phase B,65% of mobile phase A and the balance;
17-17.1min, mobile phase B,65% → 100%, mobile phase A, and the balance
17.1-27min, mobile phase B,100%;
27-27.1min, mobile phase B,100% → 65%, mobile phase A, and the balance;
27.1-37min, mobile phase B,65%, mobile phase A, and the balance;
37min,stop。
in some embodiments of the invention, the CAD parameters are: a Filter:1.0sec, range:100PA, CAD Temp:35 ℃ is carried out.
Specifically, the amount of sample is 1 to 10. Mu.L (e.g., 1, 2, 3, 4, 5, 6, 7, 8, 9, 10. Mu.L), particularly 5. Mu.L.
Specifically, the method may also suitably comprise the step of diluting the sample before the sample injection detection; more specifically, the solvent used for dilution is an organic solvent, such as one of acetonitrile, methanol and tetrahydrofuran, particularly acetonitrile.
Specifically, the method may further include a step of detecting a blank solution, which may be a diluting solvent, such as one of acetonitrile, methanol, and tetrahydrofuran, particularly acetonitrile.
In particular, the detection may be a qualitative detection or a quantitative detection, in particular a quantitative detection.
Specifically, the quantitative determination adopts a self-control method of 1% high and low concentration, and more specifically, the method further comprises the following steps: standard solutions of 100% and 1% concentration were prepared and subjected to HPLC-CAD detection.
In one embodiment of the invention, the sample is a 2-hexyldecanoic acid product, and the detection is carried out for detecting the purity of 2-hexyldecanoic acid in the product so as to provide a reference for subsequent application.
In a second aspect of the invention, there is provided the use of the method of the first aspect for the determination of the purity of 2-hexyldecanoic acid.
In a third aspect of the present invention, there is provided an application of the method of the first aspect in quality control and quality evaluation of ALC-0315.
Specifically, in the above application, ALC-0315 is prepared from 2-hexyldecanoic acid as a raw material, for example, as described in CN 114249662A:
the invention establishes an HPLC-CAD method for measuring the purity of the 2-hexyldecanoic acid, and provides information of Q-TOF high-resolution mass spectrum for larger impurities in the 2-hexyldecanoic acid, so that the information can be used as reference for subsequent quality control. The detection method provided by the invention can be used for quickly and accurately separating the product and related substances through HPLC-CAD, can be used for accurately measuring the purity of the product in a linear range, is convenient and fast to operate and good in separation, and can be used for effectively controlling the purity of the product through a high-low concentration method. The method meets the standard in the aspects of quantification, linear range and the like.
Drawings
FIG. 1 shows a liquid chromatogram for detecting a blank solution by the method of the present invention.
FIG. 2 is a liquid chromatogram of a sample solution detected by the method of the present invention.
Figure 3 shows an enlarged portion of the spectrum of figure 2.
FIG. 4 is a chromatogram showing the limit of quantitation (50 ug/mL, 0.5%) of a sample detected by the method of the present invention.
FIG. 5 shows a linear plot (SM 2 concentration 0.50% -10%) using the method of the present invention.
FIG. 6 shows a linear plot (SM 2 concentration 0.50% -3%) using the method of the present invention.
Fig. 7 shows a mass spectrum of impurity peak 1 (peak with a retention time of 0.623min, relative retention time of 0.04).
Fig. 8 shows a mass spectrum of impurity peak 1 (peak with a retention time of 0.701min, relative retention time of 0.04).
FIG. 9 shows the mass spectrum of impurity peaks 4 to 8.
FIG. 10 shows the mass spectrum of impurity peaks 4 to 8 (EIC extracted ion flux was confirmed for m/z 412.3791, which confirmed the origin of impurity peaks 4 to 8 and a subsequent cluster of peaks).
Fig. 11 shows a mass spectrum of impurity peak 9.
Fig. 12 shows a mass spectrum of the impurity peak 10.
Fig. 13 shows a mass spectrum of impurity peak 12.
FIG. 14 shows the mass spectrum of the main peak.
FIG. 15 shows an isocratic elution chromatogram with a mobile phase of 100% B.
FIG. 16 shows an isocratic elution chromatogram of 90% B (the remainder is A) of a mobile phase.
FIG. 17 shows an isocratic elution chromatogram of 80% B (balance A) of a mobile phase.
FIG. 18 shows an isocratic elution chromatogram of 75% B (balance A) of a mobile phase.
FIG. 19 shows an isocratic elution chromatogram with a mobile phase of 70% B (balance A).
FIG. 20 is a liquid chromatogram obtained by the elution procedure of example 3.
Detailed Description
Unless defined otherwise, all scientific and technical terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention pertains.
The structural formula of the 2-hexyldecanoic acid is shown in the specificationIts CAS number is 25354-97-6, sometimes referred to as "SM2" for short in the present invention. The 2-hexyl decanoic acid related substances comprise: 2-hexyldecanol; 2-hexyloctanoic acid and other unknown impurities.
The ALC-0315 is ((4-hydroxybutyl) azadiyl) bis (hexane-6, 1-diyl) bis (2-hexyldecanoate) and has a structural formula ofCAS number 2036272-55-4.
The disclosures of the various publications, patents, and published patent specifications cited herein are hereby incorporated by reference in their entirety.
The technical solutions of the present invention will be described clearly and completely below with reference to embodiments of the present invention, and it should be apparent that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
Example 1: detection of purity of 2-hexyldecanoic acid related substances
1. Test materials and methods
The instrument comprises the following steps: a ThermoUltiMate 3000 hplc;
a chromatographic column: c18 reverse phase chromatography columns (Waters, ACQUITY UPLC BEH, 2.1mm. About.100mm, 1.7 μm, S/N: 186002352);
mobile phase: MPA:0.1% fa water; MPB:0.1% of FA acetonitrile;
the parameters of the CAD instrument are as follows: a Filter:1.0sec, range:100PA, CAD Temp: at 35 deg.c.
The elution procedure is shown in table 1:
TABLE 1 elution procedure
Time(min) | 0.01 | 17 | 17.1 | 27 | 27.1 | 37 |
B% | 65 | 65 | 100 | 100 | 65 | 65 |
Flow rate: 0.3mL/min;
column temperature: at 40 ℃;
sample introduction amount: 5 mu L of the solution;
a workstation: chromeleon;
blank solution: acetonitrile;
control stock solutions: precisely weighing about 10mg of a 2-hexyldecanoic acid (SM 2) standard substance, placing the standard substance in a 10mL volumetric flask, adding a proper amount of acetonitrile for dissolving, adding the acetonitrile for constant volume until the volume is scaled, and shaking up;
sample solution: precisely weighing about 10mg of a 2-hexyldecanoic acid (SM 2) sample (Merrill, batch number (RMS 237-N22010)), precisely weighing, placing in a centrifuge tube, adding 1mL of acetonitrile for dissolving, uniformly mixing in a vortex manner to prepare a solution (100%) of 10mg/mL, and then gradually diluting to a solution (1%) of 100 mu g/mL;
limit of quantitation (LOQ) solution: precisely weighing about 10mg of 2-hexyldecanoic acid, placing the 2-hexyldecanoic acid into a centrifuge tube, adding 1mL of acetonitrile to dissolve, uniformly mixing by vortex, gradually diluting to 50 mu g/mL, and uniformly mixing by vortex.
Linear control solution: the control stock solutions (1000. Mu.g/mL) were accurately pipetted into 50. Mu.L, 80. Mu.L, 100. Mu.L, 200. Mu.L, 300. Mu.L, 400. Mu.L, 500. Mu.L, 800. Mu.L, and 1000. Mu.L volumetric flasks, and acetonitrile was added to the flasks to thereby obtain solutions of 50. Mu.g/mL, 80. Mu.g/mL, 100. Mu.g/mL, 200. Mu.g/mL, 300. Mu.g/mL, 400. Mu.g/mL, 500. Mu.g/mL, 800. Mu.g/mL, and 1000. Mu.g/mL.
TABLE 2 Linear control solution preparation
2. Results of the experiment
The liquid chromatogram of the blank solution, sample solution, and limit of quantitation (LOQ) solution are shown in FIGS. 1-4, respectively, the results of the concentrations of the linear control and the main peak areas are shown in Table 3, and the linear relationship is shown in FIGS. 5-6.
TABLE 3 Linear results for control
Concentration, μ g/mL (actual measurement value) | Main peak area, PA x min |
50.5 | 0.5496 |
80.8 | 0.9363 |
101 | 1.2190 |
202 | 2.7555 |
303 | 4.4203 |
404 | 6.0719 |
505 | 8.4958 |
808 | 14.5521 |
1010 | 19.1095 |
And (3) calculating the purity of the sample:
the blank of the diluent does not interfere at the peak position of the target substance, the purity of each peak except for a blank solvent in the sample is calculated by adopting an HPLC-CAD 1% high-low concentration self-contrast method, and each peak with the peak area percentage of more than 0.1% participates in the calculation of the purity of the 2-hexyldecanoic acid.
And (3) calculating:
C=(As/Ats)*100%
c: purity of each substance
Namely: c2-hexyldecanoic acid: purity of 2-hexyldecanoic acid; c unknown impurities: purity of each unknown impurity
As: peak area of each substance
Namely: a2-hexyldecanoic acid: peak area of 2-hexyldecanoic acid (peak area in 100% concentration sample = peak area in 1% concentration sample 100%); unknown impurities of A: peak area of each unknown impurity
At: total peak area, i.e.: unknown impurity of A2-hexyldecanoic acid + Sigma A
The concentration calculation of substances corresponding to each peak in the detection spectrum of the sample solution shown in fig. 3 is shown in the following table:
table 4 shows the peak and the concentration calculation results of the corresponding substances
* Remarking: the main peak-off time is 14.762min, and the relative retention time is calculated according to the peak-off time of the main peak.
The mass spectrum is adopted to further detect and analyze substances corresponding to each peak, and the instrument parameters are shown in the following table:
TABLE 5 Instrument parameters
The results are shown in the following table:
TABLE 6 Mass spectrometric results
* Remarking: the peak emergence time of the 2-hexyldecanoate is 14.762min, and the relative retention time is calculated according to the peak emergence time of the main peak; the table lists TOF mass spectrum information of impurity peak area >0.1% peak in 2-hexyldecanoic acid; the remaining peak areas, peak TOF greater than 0.1%, did not yield ESI + ion response.
Example 2
The test was carried out with reference to the test materials and methods of example 1, wherein the elution procedure was isocratic elution, employing respectively 100% B, 90% B, 80% B, 75% B, 70% B (balance A) the mobile phase, the resulting spectra are respectively shown in FIGS. 15-19. From 60 to 70%, in particular 65%, of B is expected to be a suitable mobile phase proportion, depending on the main peak-out position.
Example 3
The assays were performed with reference to the experimental materials and methods of example 1, with the elution procedure replaced as shown in the following table:
TABLE 7 elution procedure
Time(min) | 0 | 6 | 16 | 16.1 | 26 |
B% | 10 | 100 | 100 | 10 | 10 |
Under the elution gradient, the retention time of the main peak in the detection spectrogram (figure 20) of the sample is 10.087min, and compared with the retention time of the main peak, the positions of other impurities in the figure 20 are close to the retention time of the main peak, so that the separation is poor. The above description is only for the purpose of illustrating the preferred embodiments of the present invention and is not to be construed as limiting the invention, and any modifications, equivalents and the like that are within the spirit and principle of the present invention are included in the present invention.
The foregoing embodiments and methods described in this disclosure may vary based on the abilities, experiences, and preferences of one of ordinary skill in the art.
The mere order in which the steps of a method are listed in the present invention does not constitute any limitation on the order of the steps of the method.
Claims (10)
1. A detection method of 2-hexyldecanoic acid comprises the steps of detecting a sample to be detected by a high performance liquid chromatography-electrospray detector (HPLC-CAD);
preferably, the stationary phase of the HPLC-CAD is octadecyl bonded silica gel;
preferably, the mobile phase of the HPLC-CAD consists of a mobile phase A and a mobile phase B, wherein the mobile phase A is aqueous formic acid and has a concentration of 0.01-1% by volume; the mobile phase B is an acetonitrile solution of formic acid, and the volume percentage concentration of the mobile phase B is 0.01-1%;
preferably, the HPLC-CAD detection employs a gradient elution.
2. The method according to claim 1, wherein the stationary phase of the HPLC-CAD is of the acquire UPLC BEH series;
preferably, the stationary phase has a particle size of 1-10 μm, preferably 1-5 μm.
3. The method of claim 1, wherein the column temperature of the HPLC-CAD is 30-50 ℃, preferably 35-45 ℃, more preferably 40 ℃.
4. The method according to claim 1, characterized in that the mobile phase a is an aqueous solution of formic acid with a concentration of 0.05 to 0.2% by volume, preferably 0.1%;
the mobile phase B is acetonitrile solution of formic acid, and the volume percentage concentration of the acetonitrile solution of formic acid is 0.05-0.2%, and the volume percentage concentration of the acetonitrile solution of formic acid is preferably 0.1%.
5. The method according to any one of claims 1 to 4, wherein the flow rate of the mobile phase is 0.1 to 1mL/min, preferably 0.1 to 0.5mL/min.
6. The method of claim 5, wherein the elution procedure of the gradient elution comprises:
0-0.01min, mobile phase B,0 → 60-70%, mobile phase A, the rest;
0.01-17min, 60-70% of mobile phase B,60-70% of mobile phase A and the balance;
17-17.1min, mobile phase B,60-70% → 100%, mobile phase A, and the balance
17.1-27min, mobile phase B,100%;
27-27.1min, mobile phase B,100% → 60-70%, mobile phase A, and the balance;
27.1-37min, 60-70% of mobile phase B,60-70% of mobile phase A and the balance;
37min,stop;
preferably, the elution procedure of the gradient elution comprises:
0-0.01min, mobile phase B,0 → 65%, mobile phase A, and the balance;
0.01-17min, 65% of mobile phase B,65% of mobile phase A and the balance;
17-17.1min, mobile phase B,65% → 100%, mobile phase A, and the balance
17.1-27min, mobile phase B,100%;
27-27.1min, mobile phase B,100% → 65%, mobile phase A, the balance;
27.1-37min, mobile phase B,65%, mobile phase A, and the balance;
37min,stop。
7. the method of claim 1, further comprising the step of diluting the sample prior to sample injection detection, wherein the dilution is performed using a solvent selected from the group consisting of: one of acetonitrile, methanol and tetrahydrofuran, preferably acetonitrile.
8. The method of claim 1, wherein the CAD parameters are: a Filter:1.0sec, range:100PA, CAD Temp:35 ℃ is carried out.
9. The method of claim 1, wherein the detection is a qualitative or quantitative detection;
preferably, the quantitative detection is performed by using a self-control method with high and low concentration of 1%.
10. Use of the method of any one of claims 1-9 in quality control and quality assessment of ALC-0315.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211074923.2A CN115480005A (en) | 2022-09-02 | 2022-09-02 | Detection method and application of 2-hexyldecanoic acid |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211074923.2A CN115480005A (en) | 2022-09-02 | 2022-09-02 | Detection method and application of 2-hexyldecanoic acid |
Publications (1)
Publication Number | Publication Date |
---|---|
CN115480005A true CN115480005A (en) | 2022-12-16 |
Family
ID=84392578
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211074923.2A Pending CN115480005A (en) | 2022-09-02 | 2022-09-02 | Detection method and application of 2-hexyldecanoic acid |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115480005A (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109283283A (en) * | 2018-10-22 | 2019-01-29 | 南京威尔药业股份有限公司 | Oleic acid content and high performance liquid chromatography-electron spray formula detector measuring method in relation to substance |
CN114249662A (en) * | 2021-12-27 | 2022-03-29 | 硅羿科技(上海)有限公司 | Preparation method of medicinal liposome auxiliary material ALC-0315 |
-
2022
- 2022-09-02 CN CN202211074923.2A patent/CN115480005A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109283283A (en) * | 2018-10-22 | 2019-01-29 | 南京威尔药业股份有限公司 | Oleic acid content and high performance liquid chromatography-electron spray formula detector measuring method in relation to substance |
CN114249662A (en) * | 2021-12-27 | 2022-03-29 | 硅羿科技(上海)有限公司 | Preparation method of medicinal liposome auxiliary material ALC-0315 |
Non-Patent Citations (2)
Title |
---|
RALPH HINDLE ET AL.: "Quantitative analysis of naphthenic acids in water by liquid chromatography-accurate mass time-of-flight mass spectrometry", JOURNAL OF CHROMATOGRAPHY A, vol. 1286, pages 3 - 2 * |
中国食品药品检定研究院: "《药品检验仪器操作规程及使用指南》", 31 August 2019, 中国医药科技出版社, pages: 210 - 214 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Petrovic et al. | Recent trends in the liquid chromatography–mass spectrometry analysis of organic contaminants in environmental samples | |
CN103983725B (en) | The rapid assay methods of cumarin and safrole in a kind of essence and flavoring agent | |
Du et al. | Miniaturized solid-phase extraction of macrolide antibiotics in honey and bovine milk using mesoporous MCM-41 silica as sorbent | |
CN109696499B (en) | High-sensitivity determination method for nitrosamine in water based on high-resolution mass spectrum | |
Schappler et al. | Coupling ultra high-pressure liquid chromatography with single quadrupole mass spectrometry for the analysis of a complex drug mixture | |
Maragou et al. | Direct determination of the estrogenic compounds 8-prenylnaringenin, zearalenone, α-and β-zearalenol in beer by liquid chromatography–mass spectrometry | |
CN107941950B (en) | Method for simultaneously determining nine functional components in different parts of Changshan grapefruit by ultra-high performance liquid chromatography-tandem mass spectrometry | |
CN106645443A (en) | Method for detecting short-chain chlorinated paraffin (SCCP) and medium-chain chlorinated paraffin (MCCP) in consumer goods | |
CN106770730B (en) | A kind of methyl mercury and ethyl sclera remodeling method | |
Tang et al. | On-line multi-residue analysis of fluoroquinolones and amantadine based on an integrated microfluidic chip coupled to triple quadrupole mass spectrometry | |
KR100848132B1 (en) | Simultaneous determination of amphetamine-type stimulants and cannabinoids by gas chromatography | |
CN113075325B (en) | Method for simultaneously measuring contents of 8 index components in cynanchum wilfordii | |
CN115480005A (en) | Detection method and application of 2-hexyldecanoic acid | |
CN105784905B (en) | Ochratoxin B Liquid Chromatography-Tandem Mass Spectrometry detection method in pet food | |
KR101200423B1 (en) | High sensitive analytical method of estrogen metabolites in urine and blood obtained from postmenopausal women | |
Tsukamoto et al. | Synthesis of the isotope‐labeled derivatization reagent for carboxylic acids, 7‐(N, N‐dimethylaminosulfonyl)‐4‐(aminoethyl) piperazino‐2, 1, 3‐benzoxadiazole (d6)[DBD‐PZ‐NH2 (D)], and its application to the quantification and the determination of relative amount of fatty acids in rat plasma samples by high‐performance liquid chromatography/mass spectrometry | |
Liu et al. | Quantification of estrogens in infant formulas by isotope dilution liquid chromatography-tandem mass spectrometry | |
Li et al. | Sensitive determination of two major mercapturic acid metabolites of 1, 3-butadiene in human urine based on the isotope dilution ultrahigh performance liquid chromatography-tandem mass spectrometry | |
Li et al. | Simultaneous determination of seven residual pharmaceuticals in wastewater by solid-phase extraction and liquid chromatography coupled to tandem mass spectrometry with a switching ionization mode | |
CN114217002A (en) | Method for detecting content of chamomile azulene and sabinene in blumea oil | |
CN105699575A (en) | Method and kit for testing cortisol in saliva by efficient liquid chromatogram and tandem mass spectrometry combination technology | |
Meermann et al. | Iodine speciation using thin-layer chromatography coupled to inductively coupled plasma-mass spectrometry by means of an extraction device | |
CN112461982A (en) | Detection method of L-camphorsulfonic acid methyl ester and L-camphorsulfonic acid ethyl ester | |
CN108008035B (en) | Method for detecting purity of 3-ethoxy-4-methoxybenzaldehyde | |
CN105806979B (en) | The liquid chromatography-tandem mass of ochratoxin A in dog chew |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |